Loading...
Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
Locally advanced hepatocellular carcinoma (HCC) with portal vein thrombosis carries a 1-year survival rate <10%. Localized concurrent chemoradiotherapy (CCRT), followed by hepatic arterial infusion chemotherapy (HAIC), was recently introduced in this setting. Here, we report our early experience...
Na minha lista:
| Udgivet i: | Yonsei Med J |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Yonsei University College of Medicine
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4960397/ https://ncbi.nlm.nih.gov/pubmed/27401662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2016.57.5.1276 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|